Kozo Miyatani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kozo Miyatani has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
Tomoyuki Matsunaga
Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Japan
26 shared publicationsYoshiyuki Fujiwara
Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Japan
19 shared publicationsYoji Fukumoto
Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, Tottori, 683-8504, Japan
18 shared publicationsYuji Shishido
Faculty of Medicine, Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University, Yonago, Japan
17 shared publications- Hiroaki Saito
Department of Surgery, Japanese Red Cross Tottori Hospital, Tottori, Japan
16 shared publications Shota Shimizu
Faculty of Medicine, Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University, Yonago, Japan
14 shared publications
Latest Publications
- Open Access
- 6 April 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Climbing the ladder of confidence: effects of the step ladder system on medical students’ self-efficacy during a surgical clerkship
Background: Self-efficacy is a key factor in motivation, persistence, and performance in medical education. However, surgical clerkships often provide limited hands-on practice and inconsistent feedback, hindering students’ ability to recognize their learning progress or readiness. The Step Ladder System (SLS), a structured competency-based framework, was introduced to clarify expectations and support incremental learning by helping students visualize progress and document task achievements. This study examined changes in medical students’ self-efficacy during a surgical clerkship and investigated whether participation in the SLS was linked to self-efficacy growth. Methods: An observational study using prospective and retrospective data was conducted among 24 sixth-year medical students who completed a four-week clerkship in gastroentintestinal and pediatric surgery at Tottori University in 2025. Self-efficacy was measured with the General Self-Efficacy Scale (GSES) at the start and end of the rotation. SLS engagement was calculated as the total number of task entries submitted via the mobile app. Paired t-tests evaluated pre- and post-rotation changes, while binomial tests analyzed directional trends in ΔGSES. Results: Standardized GSES scores increased significantly from pre- to post-clerkship (49.8 ± 11.0 to 53.8 ± 12.2; p = 0.009). Students with high SLS engagement were more likely to show positive rather than negative ΔGSES ( p = 0.021), while no clear trend was observed in low-engagement students. Learners with lower baseline GSES showed a significant predominance of positive ΔGSES ( p = 0.031). Conclusions: Medical students’ self-efficacy improved over the clerkship. The SLS is designed as a learner-facing scaffold that supports clarification of expectations and structured preparation, rather than a tool for summative competency assessment. The SLS may support this growth by clarifying expected learning targets and expectations, encouraging purposeful preparation, and providing clearer goals and structured mastery experiences. Although SLS engagement and the magnitude of ΔGSES were not proportional, greater engagement and lower initial self-efficacy were consistently associated with positive change, suggesting that structured task engagement influences self-efficacy through non-linear mechanisms. The SLS appears to be a feasible and potentially beneficial framework for learner-centered surgical education.
- 6 April 2026
- Published by Springer Nature in BMC Medical Education
- Vol. 26 (1)
Open AccessClimbing the ladder of confidence: effects of the step ladder system on medical students’ self-efficacy during a surgical clerkship
Background: Self-efficacy is a key factor in motivation, persistence, and performance in medical education. However, surgical clerkships often provide limited hands-on practice and inconsistent feedback, hindering students’ ability to recognize their learning progress or readiness. The Step Ladder System (SLS), a structured competency-based framework, was introduced to clarify expectations and support incremental learning by helping students visualize progress and document task achievements. This study examined changes in medical students’ self-efficacy during a surgical clerkship and investigated whether participation in the SLS was linked to self-efficacy growth. Methods: An observational study using prospective and retrospective data was conducted among 24 sixth-year medical students who completed a four-week clerkship in gastroentintestinal and pediatric surgery at Tottori University in 2025. Self-efficacy was measured with the General Self-Efficacy Scale (GSES) at the start and end of the rotation. SLS engagement was calculated as the total number of task entries submitted via the mobile app. Paired t-tests evaluated pre- and post-rotation changes, while binomial tests analyzed directional trends in ΔGSES. Results: Standardized GSES scores increased significantly from pre- to post-clerkship (49.8 ± 11.0 to 53.8 ± 12.2; p = 0.009). Students with high SLS engagement were more likely to show positive rather than negative ΔGSES ( p = 0.021), while no clear trend was observed in low-engagement students. Learners with lower baseline GSES showed a significant predominance of positive ΔGSES ( p = 0.031). Conclusions: Medical students’ self-efficacy improved over the clerkship. The SLS is designed as a learner-facing scaffold that supports clarification of expectations and structured preparation, rather than a tool for summative competency assessment. The SLS may support this growth by clarifying expected learning targets and expectations, encouraging purposeful preparation, and providing clearer goals and structured mastery experiences. Although SLS engagement and the magnitude of ΔGSES were not proportional, greater engagement and lower initial self-efficacy were consistently associated with positive change, suggesting that structured task engagement influences self-efficacy through non-linear mechanisms. The SLS appears to be a feasible and potentially beneficial framework for learner-centered surgical education.
- 27 March 2026
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 46 (4) , 2063-2076
Impact of Postoperative Prognostic Nutritional Index on Post-gastrectomy Outcomes in Older Adults With Gastric Cancer
This study aimed to clarify the impact of preoperative and postoperative inflammation and nutritional markers on post-gastrectomy outcomes in older adult patients with gastric cancer (GC) using data from multiple institutions. We enrolled 273 patients aged ≥75 years who were diagnosed with GC and underwent gastrectomy. The prognostic impact of six preoperative and postoperative inflammation and nutritional markers was compared. Comparison of the area under the receiver operating characteristic curve (AUC) among the six markers revealed that the prognostic nutritional index (PNI) demonstrated the highest AUC in both preoperative and postoperative values, indicating that preoperative and postoperative PNIs had the highest predictive value. Considering the utility of preoperative and postoperative PNIs and their combined value as overall survival (OS) predictors in older adult patients with GC, preoperative PNI and the combined value were identified as valuable OS predictors across all patients and in those with early GC but not in those with advanced GC. Conversely, postoperative PNI alone accurately predicted the prognosis in the overall analysis and stage-specific analyses. Further analysis revealed that higher postoperative PNI was associated with a higher laparoscopic surgery proportion and a lower postoperative complication incidence. Multivariate analysis indicated that a postoperative PNI of <41.3 was an independent prognostic factor for OS. Higher postoperative PNI is correlated with better OS in older adult patients with GC who underwent gastrectomy.
- 27 March 2026
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 46 (4) , 2063-2076
Impact of Postoperative Prognostic Nutritional Index on Post-gastrectomy Outcomes in Older Adults With Gastric Cancer
This study aimed to clarify the impact of preoperative and postoperative inflammation and nutritional markers on post-gastrectomy outcomes in older adult patients with gastric cancer (GC) using data from multiple institutions. We enrolled 273 patients aged ≥75 years who were diagnosed with GC and underwent gastrectomy. The prognostic impact of six preoperative and postoperative inflammation and nutritional markers was compared. Comparison of the area under the receiver operating characteristic curve (AUC) among the six markers revealed that the prognostic nutritional index (PNI) demonstrated the highest AUC in both preoperative and postoperative values, indicating that preoperative and postoperative PNIs had the highest predictive value. Considering the utility of preoperative and postoperative PNIs and their combined value as overall survival (OS) predictors in older adult patients with GC, preoperative PNI and the combined value were identified as valuable OS predictors across all patients and in those with early GC but not in those with advanced GC. Conversely, postoperative PNI alone accurately predicted the prognosis in the overall analysis and stage-specific analyses. Further analysis revealed that higher postoperative PNI was associated with a higher laparoscopic surgery proportion and a lower postoperative complication incidence. Multivariate analysis indicated that a postoperative PNI of <41.3 was an independent prognostic factor for OS. Higher postoperative PNI is correlated with better OS in older adult patients with GC who underwent gastrectomy.
- 16 April 2025
- Published by Springer Nature in Surgery Today
- p. 1-11
A higher preoperative cachexia index can result in the sufficient administration of S-1 adjuvant chemotherapy and lead to a good prognosis for elderly patients with stage II/III gastric cancer
Purpose This study aimed to clarify the significance of the relative dose intensity (RDI) of S-1 adjuvant chemotherapy (ACT) after gastrectomy in elderly patients with stage II/III gastric cancer (GC) and to determine whether the cachexia index (CXI) correlates with RDI. Methods We enrolled 76 patients with stage II/III GC, aged > 70 years. The overall survival (OS) and disease-specific survival (DSS) of participants in the surgery alone, S-1 ACT completion (RDI ≥ 58%), and S-1 ACT non-completion (RDI < 58%) groups were compared. In addition, the clinicopathological determinants of RDI were examined. Results The S-1 ACT completion group had better OS and DSS, while the prognoses of patients in the surgery alone and S-1 ACT non-completion groups did not differ significantly. S-1 ACT non-completion or surgery alone was identified as an independent poor prognostic factor for OS and DSS. Furthermore, a multivariate analysis revealed that a high preoperative CXI (≥ 75.5 for males and ≥ 79.4 for females) was an independent predictor of success in achieving an RDI ≥ 58%. Conclusions A higher preoperative CXI can result in a higher RDI and improve the prognosis of elderly patients with stage II/III GC who underwent S-1 ACT.
- 16 April 2025
- Published by Springer Nature in Surgery Today
- p. 1-11
A higher preoperative cachexia index can result in the sufficient administration of S-1 adjuvant chemotherapy and lead to a good prognosis for elderly patients with stage II/III gastric cancer
Purpose This study aimed to clarify the significance of the relative dose intensity (RDI) of S-1 adjuvant chemotherapy (ACT) after gastrectomy in elderly patients with stage II/III gastric cancer (GC) and to determine whether the cachexia index (CXI) correlates with RDI. Methods We enrolled 76 patients with stage II/III GC, aged > 70 years. The overall survival (OS) and disease-specific survival (DSS) of participants in the surgery alone, S-1 ACT completion (RDI ≥ 58%), and S-1 ACT non-completion (RDI < 58%) groups were compared. In addition, the clinicopathological determinants of RDI were examined. Results The S-1 ACT completion group had better OS and DSS, while the prognoses of patients in the surgery alone and S-1 ACT non-completion groups did not differ significantly. S-1 ACT non-completion or surgery alone was identified as an independent poor prognostic factor for OS and DSS. Furthermore, a multivariate analysis revealed that a high preoperative CXI (≥ 75.5 for males and ≥ 79.4 for females) was an independent predictor of success in achieving an RDI ≥ 58%. Conclusions A higher preoperative CXI can result in a higher RDI and improve the prognosis of elderly patients with stage II/III GC who underwent S-1 ACT.
- Open Access
- 24 May 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (21) , e38292
Correlation between relative dose intensity of adjuvant S-1 chemotherapy and psoas muscle mass volume and survival after resection of pancreatic ductal adenocarcinoma: A retrospective study
This study aimed to investigate the prognostic relationship between relative dose intensity (RDI) of adjuvant S-1 chemotherapy and psoas muscle mass volume (PMV) in patients with resected pancreatic ductal adenocarcinoma. We enrolled 105 patients with histologically confirmed pancreatic ductal adenocarcinoma who had undergone pancreatectomy. Adjuvant S-1 chemotherapy was administered to 72 (68.6%) of the 105 patients and not to the remaining 33 patients. Patients who received adjuvant S-1 chemotherapy were stratified into high- and low-RDI groups by the cutoff value for RDI. Five-year overall survival (OS) and relapse-free survival (RFS) rates were significantly higher in the high- than in the low-RDI group. Similarly, both the 5-year OS and RFS rates were significantly greater among patients in the high-PMV group than among patients in the low-PMV group. The RDI was an independent prognostic factor in our study patients. Furthermore, patients who received adjuvant S-1 chemotherapy were stratified into 3 groups: those with both high RDI and high-PMV, Group A; those with either high RDI or high PMV (but not both), Group B; and those with both low RDI and low-PMV, group C. There were statistically significant differences in 5-year OS and RFS between 3 patient groups (5-year overall survival: P = .023, 5-year relapse-free survival: P = .001). The area under the curve for the combination of RDI and PMV (0.674) was greater than that for RDI alone (0.645). A sufficient dosage of adjuvant S-1 chemotherapy is important in improving survival of patients with resected pancreatic ductal adenocarcinoma. A combination of RDI and PMV may predict the prognosis of patients with resected pancreatic ductal adenocarcinoma more effective than RDI alone.
- 24 May 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (21) , e38292
Open AccessCorrelation between relative dose intensity of adjuvant S-1 chemotherapy and psoas muscle mass volume and survival after resection of pancreatic ductal adenocarcinoma: A retrospective study
This study aimed to investigate the prognostic relationship between relative dose intensity (RDI) of adjuvant S-1 chemotherapy and psoas muscle mass volume (PMV) in patients with resected pancreatic ductal adenocarcinoma. We enrolled 105 patients with histologically confirmed pancreatic ductal adenocarcinoma who had undergone pancreatectomy. Adjuvant S-1 chemotherapy was administered to 72 (68.6%) of the 105 patients and not to the remaining 33 patients. Patients who received adjuvant S-1 chemotherapy were stratified into high- and low-RDI groups by the cutoff value for RDI. Five-year overall survival (OS) and relapse-free survival (RFS) rates were significantly higher in the high- than in the low-RDI group. Similarly, both the 5-year OS and RFS rates were significantly greater among patients in the high-PMV group than among patients in the low-PMV group. The RDI was an independent prognostic factor in our study patients. Furthermore, patients who received adjuvant S-1 chemotherapy were stratified into 3 groups: those with both high RDI and high-PMV, Group A; those with either high RDI or high PMV (but not both), Group B; and those with both low RDI and low-PMV, group C. There were statistically significant differences in 5-year OS and RFS between 3 patient groups (5-year overall survival: P = .023, 5-year relapse-free survival: P = .001). The area under the curve for the combination of RDI and PMV (0.674) was greater than that for RDI alone (0.645). A sufficient dosage of adjuvant S-1 chemotherapy is important in improving survival of patients with resected pancreatic ductal adenocarcinoma. A combination of RDI and PMV may predict the prognosis of patients with resected pancreatic ductal adenocarcinoma more effective than RDI alone.
- Open Access
- 2 May 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis
Intraperitoneal (IP) chemotherapy with paclitaxel (PTX) for gastric cancer (GC) with peritoneal metastasis (PM) is considered a promising treatment approach, however, there are no useful biomarkers to predict the efficacy of IP therapy. We examined the association between intra-peritoneal exosomes, particularly exosomal micro-RNAs (exo-miRNAs), and IP-chemo sensitivity. MKN45 cells that were cultured with intra-peritoneal exosomes from patients who did not respond to IP therapy with PTX (IPnon-respond group) exhibited resistance to PTX compared with exosomes from responding patients (IPrespond group) (p = 0.002). A comprehensive search for exo-miRNAs indicated that miR-493 was significantly up-regulated in exosomes from the IPnon-respond group compared with those collected from the IPrespond group. The expression of miR-493 in PTX-resistant MKN45 cells (MKN45PTX-res) was higher compared with that in MKN45. In addition, MKN45PTX-res cells exhibited lower MAD2L1 gene and protein expression compared with MKN45. Finally, miR-493 enhancement by transfection of miR-493 mimics significantly down-regulated MAD2L1 expression in MKN45 cells and reduced PTX sensitivity. Our results suggest that intra-peritoneal exo-miR-493 is involved in chemoresistance to PTX by downregulating MAD2L1 in GC with PM. Exo-miR-493 may be a biomarker for chemoresistance and prognosis of GC patients with PM and may also be a promising therapeutic target.
- 2 May 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Open AccessExosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis
Intraperitoneal (IP) chemotherapy with paclitaxel (PTX) for gastric cancer (GC) with peritoneal metastasis (PM) is considered a promising treatment approach, however, there are no useful biomarkers to predict the efficacy of IP therapy. We examined the association between intra-peritoneal exosomes, particularly exosomal micro-RNAs (exo-miRNAs), and IP-chemo sensitivity. MKN45 cells that were cultured with intra-peritoneal exosomes from patients who did not respond to IP therapy with PTX (IPnon-respond group) exhibited resistance to PTX compared with exosomes from responding patients (IPrespond group) (p = 0.002). A comprehensive search for exo-miRNAs indicated that miR-493 was significantly up-regulated in exosomes from the IPnon-respond group compared with those collected from the IPrespond group. The expression of miR-493 in PTX-resistant MKN45 cells (MKN45PTX-res) was higher compared with that in MKN45. In addition, MKN45PTX-res cells exhibited lower MAD2L1 gene and protein expression compared with MKN45. Finally, miR-493 enhancement by transfection of miR-493 mimics significantly down-regulated MAD2L1 expression in MKN45 cells and reduced PTX sensitivity. Our results suggest that intra-peritoneal exo-miR-493 is involved in chemoresistance to PTX by downregulating MAD2L1 in GC with PM. Exo-miR-493 may be a biomarker for chemoresistance and prognosis of GC patients with PM and may also be a promising therapeutic target.
- 18 April 2023
- Published by Springer Nature in Surgery Today
- Vol. 53 (11) , 1294-1304
A low cumulative perioperative prognostic nutritional index predicts poor long-term outcomes in patients with gastric cancer: A single-center retrospective study in Japan
Purpose Perioperative surgical stress and systemic inflammation resulting from complex interactions between cancer and the host play an important role in cancer progression. This retrospective study compared the prognostic impact of various perioperative cumulative inflammation- and nutrition-based markers in patients with gastric cancer (GC). Methods This study included 301 patients with a histopathological diagnosis of gastric adenocarcinoma who underwent curative surgery. Perioperative cumulative markers were calculated using the newly developed trapezoidal area method. Results The cumulative prognostic nutritional index (cum-PNI) had the highest area under the receiver operating characteristic (ROC) curve for predicting the overall survival (OS) as well as the relapse-free survival (RFS). The cum-PNI was significantly correlated with tumor-related factors, including tumor size, depth of invasion, lymph node metastasis, lymphatic involvement, vascular involvement, and TNM stage classification. The cum-PNI was also significantly correlated with surgical factors, including surgical approach, gastrectomy, lymphadenectomy, intraoperative blood loss, and postoperative complications. Furthermore, the OS and RFS were poorer in patients with a low cum-PNI (< 236.3) than in those with a high cum-PNI (> 236.3). A multivariate analysis indicated that a low cum-PNI was an independent prognostic indicator in patients with GC. Conclusions The cum-PNI might be useful for predicting the prognosis and guiding the perioperative management of patients with GC.
- 18 April 2023
- Published by Springer Nature in Surgery Today
- Vol. 53 (11) , 1294-1304
A low cumulative perioperative prognostic nutritional index predicts poor long-term outcomes in patients with gastric cancer: A single-center retrospective study in Japan
Purpose Perioperative surgical stress and systemic inflammation resulting from complex interactions between cancer and the host play an important role in cancer progression. This retrospective study compared the prognostic impact of various perioperative cumulative inflammation- and nutrition-based markers in patients with gastric cancer (GC). Methods This study included 301 patients with a histopathological diagnosis of gastric adenocarcinoma who underwent curative surgery. Perioperative cumulative markers were calculated using the newly developed trapezoidal area method. Results The cumulative prognostic nutritional index (cum-PNI) had the highest area under the receiver operating characteristic (ROC) curve for predicting the overall survival (OS) as well as the relapse-free survival (RFS). The cum-PNI was significantly correlated with tumor-related factors, including tumor size, depth of invasion, lymph node metastasis, lymphatic involvement, vascular involvement, and TNM stage classification. The cum-PNI was also significantly correlated with surgical factors, including surgical approach, gastrectomy, lymphadenectomy, intraoperative blood loss, and postoperative complications. Furthermore, the OS and RFS were poorer in patients with a low cum-PNI (< 236.3) than in those with a high cum-PNI (> 236.3). A multivariate analysis indicated that a low cum-PNI was an independent prognostic indicator in patients with GC. Conclusions The cum-PNI might be useful for predicting the prognosis and guiding the perioperative management of patients with GC.
- Open Access
- 7 October 2022
- Published by Springer Nature in Surgical Case Reports
- Vol. 8 (1) , 1-8
Robot-assisted total pelvic exenteration for rectal cancer after neoadjuvant chemoradiotherapy: a case report
Background: There are numerous indications for minimally invasive surgery. However, the laparoscopic approach for extended pelvic surgery is currently provided by only a few institutions specializing in cancer treatment, primarily because of technical difficulties that arise in cases involving a narrow pelvis and rigid forceps. We report a case of robot-assisted total pelvic exenteration for rectal cancer involving the prostate. We assessed the feasibility of robot-assisted total pelvic exenteration and compared the short-term outcomes of other conventional and minimally invasive approaches.Case presentation: A 67-year-old man was referred to our hospital after positive fecal blood test results. The initial diagnosis was clinical T4bN2aM0, Stage IIIC rectal cancer involving the prostate. The patient underwent neoadjuvant chemoradiotherapy. Consequently, robot-assisted total pelvic exenteration with an ileal conduit and end colostomy creation were performed. The total operative duration was 9 h and 20 min. The durations of robot console usage by the colorectal and urological teams were 2 h 9 min and 2 h 23 min, respectively. The patient was discharged on postoperative day 21. The pathological diagnosis was T4b (prostate) N0M0, Stage IIC. The resection margin was 2.5 mm. During reassessment at 2 years after resection, no evidence of recurrence was observed.Conclusions: Robot-assisted total pelvic exenteration was performed for a patient with advanced rectal cancer without serious complications. Robot-assisted total pelvic exenteration may provide the advantages of minimally invasive surgery, particularly in the enclosed space of the pelvis.
- 7 October 2022
- Published by Springer Nature in Surgical Case Reports
- Vol. 8 (1) , 1-8
Open AccessRobot-assisted total pelvic exenteration for rectal cancer after neoadjuvant chemoradiotherapy: a case report
Background: There are numerous indications for minimally invasive surgery. However, the laparoscopic approach for extended pelvic surgery is currently provided by only a few institutions specializing in cancer treatment, primarily because of technical difficulties that arise in cases involving a narrow pelvis and rigid forceps. We report a case of robot-assisted total pelvic exenteration for rectal cancer involving the prostate. We assessed the feasibility of robot-assisted total pelvic exenteration and compared the short-term outcomes of other conventional and minimally invasive approaches.Case presentation: A 67-year-old man was referred to our hospital after positive fecal blood test results. The initial diagnosis was clinical T4bN2aM0, Stage IIIC rectal cancer involving the prostate. The patient underwent neoadjuvant chemoradiotherapy. Consequently, robot-assisted total pelvic exenteration with an ileal conduit and end colostomy creation were performed. The total operative duration was 9 h and 20 min. The durations of robot console usage by the colorectal and urological teams were 2 h 9 min and 2 h 23 min, respectively. The patient was discharged on postoperative day 21. The pathological diagnosis was T4b (prostate) N0M0, Stage IIC. The resection margin was 2.5 mm. During reassessment at 2 years after resection, no evidence of recurrence was observed.Conclusions: Robot-assisted total pelvic exenteration was performed for a patient with advanced rectal cancer without serious complications. Robot-assisted total pelvic exenteration may provide the advantages of minimally invasive surgery, particularly in the enclosed space of the pelvis.
- Open Access
- 11 June 2022
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-14
Combined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer
Background: The systemic inflammatory response resulting from the complex interactions between cancer and the host plays an important role in cancer development. Recently, the lymphocyte-C-reactive protein ratio (LCR), which is a hematological and biochemical marker that reflects the systemic inflammatory response and nutritional status, has been reported to be associated with poor survival. Similar results were observed in patients with certain cancer types. However, these studies focused on the preoperative LCR, and thus far, no studies have reported the relationship between postoperative LCR and prognosis in patients with gastric cancer (GC). Methods: This study enrolled 455 patients with a histopathological diagnosis of gastric adenocarcinoma who underwent curative surgery at our institution between 2005 and 2018. The relationship between both the preoperative and postoperative LCR and the prognosis of patients with GC was retrospectively investigated. Results: Preoperative LCR showed significant correlations with tumor-related factors, such as tumor size, depth of invasion, and lymph node metastasis. By contrast, no correlation was observed between postoperative LCR and tumor-related factors. The 5 year survival rate was significantly worse in patients with low preoperative LCR than in those with high preoperative LCR (65.4% vs. 83.9%, p < 0.0001). Similarly, the 5 year survival rate was also significantly worse in patients with low postoperative LCR than in those with high postoperative LCR (67.0% vs. 84.1%, p < 0.0001). Furthermore, combination analysis of the pre- and postoperative LCR revealed that the prognosis of patients with both low pre- and postoperative LCR was worse in patients with GC (5 year survival rate was 52.0%). A multivariate analysis indicated that a low pre- and postoperative LCR and age and lymph node metastasis were independent prognostic indicators. Conclusions: The combination of preoperative and postoperative LCR appears to be useful in predicting the prognosis of patients with GC.
- 11 June 2022
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-14
Open AccessCombined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer
Background: The systemic inflammatory response resulting from the complex interactions between cancer and the host plays an important role in cancer development. Recently, the lymphocyte-C-reactive protein ratio (LCR), which is a hematological and biochemical marker that reflects the systemic inflammatory response and nutritional status, has been reported to be associated with poor survival. Similar results were observed in patients with certain cancer types. However, these studies focused on the preoperative LCR, and thus far, no studies have reported the relationship between postoperative LCR and prognosis in patients with gastric cancer (GC). Methods: This study enrolled 455 patients with a histopathological diagnosis of gastric adenocarcinoma who underwent curative surgery at our institution between 2005 and 2018. The relationship between both the preoperative and postoperative LCR and the prognosis of patients with GC was retrospectively investigated. Results: Preoperative LCR showed significant correlations with tumor-related factors, such as tumor size, depth of invasion, and lymph node metastasis. By contrast, no correlation was observed between postoperative LCR and tumor-related factors. The 5 year survival rate was significantly worse in patients with low preoperative LCR than in those with high preoperative LCR (65.4% vs. 83.9%, p < 0.0001). Similarly, the 5 year survival rate was also significantly worse in patients with low postoperative LCR than in those with high postoperative LCR (67.0% vs. 84.1%, p < 0.0001). Furthermore, combination analysis of the pre- and postoperative LCR revealed that the prognosis of patients with both low pre- and postoperative LCR was worse in patients with GC (5 year survival rate was 52.0%). A multivariate analysis indicated that a low pre- and postoperative LCR and age and lymph node metastasis were independent prognostic indicators. Conclusions: The combination of preoperative and postoperative LCR appears to be useful in predicting the prognosis of patients with GC.
- Open Access
- 16 February 2022
- Published by Springer Nature in Research Square
Combined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer
Background: The systemic inflammatory response resulting from the complex interactions between cancer and the host plays an important role in cancer development. Recently, the lymphocyte-C-reactive protein ratio (LCR), which is a hematological and biochemical marker that reflects the systemic inflammatory response and nutritional status, has been reported to be associated with poor survival. Similar results were observed in patients with certain cancer types. However, these studies focused on the preoperative LCR, and thus far, no studies have reported the relationship between postoperative LCR and prognosis in patients with gastric cancer (GC).Methods: This study enrolled 455 patients with a histopathological diagnosis of gastric adenocarcinoma who underwent curative surgery at our institution between 2005 and 2018. The relationship between both the preoperative and postoperative LCR and the prognosis of patients with GC was retrospectively investigated.Results: Preoperative LCR showed significant correlations with tumor-related factors, such as tumor size, depth of invasion, and lymph node metastasis. By contrast, no correlation was observed between postoperative LCR and tumor-related factors. The 5 year survival rate was significantly worse in patients with low preoperative LCR than in those with high preoperative LCR (65.4% vs. 83.9%, p < 0.0001). Similarly, the 5 year survival rate was also significantly worse in patients with low postoperative LCR than in those with high postoperative LCR (67.0% vs. 84.1%, p < 0.0001). Furthermore, combination analysis of the preoperative and postoperative LCR revealed that the prognosis of patients with both low preoperative and postoperative LCR was worse in patients with GC (5 year survival rate was 52.0%). A multivariate analysis indicated that a low preoperative and postoperative LCR and age and lymph node metastasis were independent prognostic indicators.Conclusions: The combination of preoperative and postoperative LCR appears to be useful in predicting the prognosis of patients with GC.
- 16 February 2022
- Published by Springer Nature in Research Square
Open AccessCombined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer
Background: The systemic inflammatory response resulting from the complex interactions between cancer and the host plays an important role in cancer development. Recently, the lymphocyte-C-reactive protein ratio (LCR), which is a hematological and biochemical marker that reflects the systemic inflammatory response and nutritional status, has been reported to be associated with poor survival. Similar results were observed in patients with certain cancer types. However, these studies focused on the preoperative LCR, and thus far, no studies have reported the relationship between postoperative LCR and prognosis in patients with gastric cancer (GC).Methods: This study enrolled 455 patients with a histopathological diagnosis of gastric adenocarcinoma who underwent curative surgery at our institution between 2005 and 2018. The relationship between both the preoperative and postoperative LCR and the prognosis of patients with GC was retrospectively investigated.Results: Preoperative LCR showed significant correlations with tumor-related factors, such as tumor size, depth of invasion, and lymph node metastasis. By contrast, no correlation was observed between postoperative LCR and tumor-related factors. The 5 year survival rate was significantly worse in patients with low preoperative LCR than in those with high preoperative LCR (65.4% vs. 83.9%, p < 0.0001). Similarly, the 5 year survival rate was also significantly worse in patients with low postoperative LCR than in those with high postoperative LCR (67.0% vs. 84.1%, p < 0.0001). Furthermore, combination analysis of the preoperative and postoperative LCR revealed that the prognosis of patients with both low preoperative and postoperative LCR was worse in patients with GC (5 year survival rate was 52.0%). A multivariate analysis indicated that a low preoperative and postoperative LCR and age and lymph node metastasis were independent prognostic indicators.Conclusions: The combination of preoperative and postoperative LCR appears to be useful in predicting the prognosis of patients with GC.
- Open Access
- 18 December 2021
- Published by Springer Nature in Surgical Case Reports
- Vol. 7 (1) , 1-6
Colonic metastasis of hepatocellular carcinoma with repeated retroperitoneal bleeding: a case report
Background: Colonic metastasis is uncommon in patients with hepatocellular carcinoma (HCC). In the past, extrahepatic metastasis of HCC was not treated aggressively because of its poor prognosis. Herein, we describe the case of a patient with HCC who survived for 30 months following resection of a metastatic tumor in the ascending colon.Case presentation: An 80-year-old man presented at our hospital with symptoms of abdominal pain on the right side and fever. He had undergone transcatheter arterial chemoembolization and posterior segment resection of the liver because of HCC, followed by radiofrequency ablation for a recurrent intrahepatic lesion 5 and 3 years, respectively, prior to the visit. He was diagnosed with retroperitoneal hematoma, which was thought to be associated with diverticulitis and an extramural tumor in the ascending colon. A definitive diagnosis could not be reached; however, a right hemicolectomy of the colon was performed because of progression to anemia. A pathological examination revealed a metastatic tumor in the ascending colon extending from the subserosal layer to the muscularis propria layer. The patient was treated with lenvatinib after surgery, but presented with intrahepatic recurrence, lymph node metastasis, and peritoneal dissemination metastasis 15 months later. The progression of the disease could not be controlled and his postoperative survival time was 30 months.Conclusion: Resection of metastasis of HCC might contribute to prolonged survival in cases, where radical resection is possible.
- 18 December 2021
- Published by Springer Nature in Surgical Case Reports
- Vol. 7 (1) , 1-6
Open AccessColonic metastasis of hepatocellular carcinoma with repeated retroperitoneal bleeding: a case report
Background: Colonic metastasis is uncommon in patients with hepatocellular carcinoma (HCC). In the past, extrahepatic metastasis of HCC was not treated aggressively because of its poor prognosis. Herein, we describe the case of a patient with HCC who survived for 30 months following resection of a metastatic tumor in the ascending colon.Case presentation: An 80-year-old man presented at our hospital with symptoms of abdominal pain on the right side and fever. He had undergone transcatheter arterial chemoembolization and posterior segment resection of the liver because of HCC, followed by radiofrequency ablation for a recurrent intrahepatic lesion 5 and 3 years, respectively, prior to the visit. He was diagnosed with retroperitoneal hematoma, which was thought to be associated with diverticulitis and an extramural tumor in the ascending colon. A definitive diagnosis could not be reached; however, a right hemicolectomy of the colon was performed because of progression to anemia. A pathological examination revealed a metastatic tumor in the ascending colon extending from the subserosal layer to the muscularis propria layer. The patient was treated with lenvatinib after surgery, but presented with intrahepatic recurrence, lymph node metastasis, and peritoneal dissemination metastasis 15 months later. The progression of the disease could not be controlled and his postoperative survival time was 30 months.Conclusion: Resection of metastasis of HCC might contribute to prolonged survival in cases, where radical resection is possible.